TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 11.38%-4.31M | 54.10%-11.87M | 75.97%-4.86M | 11.26%-25.87M | -19.53%-20.22M | 56.43%-29.15M | 39.79%-16.92M | 31.76%-66.9M | 57.09%-28.09M | -184.17%-98.04M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 3.74%-103K | -42.05%-250K | -328.00%-107K | -238.46%-176K | -316.67%-25K | -6.12%-52K | 85.71%-6K | 94.30%-49K | 94.44%-42K | 52.20%-860K |
Attributable subsidiary (profit) loss | 76.92%-72K | 132.99%158K | ---312K | ---479K | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | -920.51%-320K | 92.60%1.33M | -86.64%39K | 882.95%689K | 115.18%292K | -100.23%-88K | -102.21%-1.92M | 5.02%37.99M | -102.15%-951K | 725.59%36.17M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | -85.52%5.01M | ---- | 1,355.99%34.61M | ---- | --2.38M |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -398.15%-2.16M |
-Impairment of trade receivables (reversal) | -920.51%-320K | 194.35%234K | -86.64%39K | 86.28%-248K | 115.18%292K | -163.24%-1.81M | 28.41%-1.92M | -87.30%2.86M | -109.64%-2.69M | 350.08%22.5M |
-Other impairments and provisions | ---- | 16.65%1.09M | ---- | 128.48%937K | ---- | -735.14%-3.29M | ---- | -96.15%518K | -90.63%1.74M | 7,328.49%13.45M |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -121.27%-3.41M | 77.48%-309K | 94.01%-1.54M |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.45%-101K | 92.64%-101K | 94.01%-1.54M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.31M | ---208K | ---- |
Asset sale loss (gain): | ---- | -105.75%-5K | -108.57%-3K | -81.88%87K | -92.65%35K | 9.84%480K | 20.51%476K | 3,021.43%437K | 2,368.75%395K | 100.01%14K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -105.75%-5K | -108.57%-3K | -81.88%87K | -92.65%35K | 9.84%480K | 20.51%476K | 3,021.43%437K | 2,368.75%395K | 100.09%14K |
Depreciation and amortization: | -1.61%2.26M | -18.51%4.6M | -33.82%2.29M | -47.27%5.64M | -38.06%3.47M | -38.86%10.7M | -32.97%5.59M | 33.15%17.5M | 49.54%8.35M | 44.51%13.14M |
-Depreciation | 0.65%2.15M | -19.58%4.29M | -35.40%2.14M | -48.67%5.33M | -39.14%3.31M | -39.92%10.39M | -34.42%5.44M | 31.59%17.29M | 48.63%8.3M | 49.44%13.14M |
-Amortization of intangible assets | -33.12%103K | 0.00%308K | 0.00%154K | 0.00%308K | 0.00%154K | 50.24%308K | 201.96%154K | --205K | --51K | ---- |
Financial expense | -9.52%19K | -87.97%32K | -90.95%21K | -88.15%266K | -85.14%232K | -70.69%2.24M | -68.25%1.56M | -57.15%7.66M | -62.09%4.92M | 19.54%17.86M |
Special items | ---- | -99.85%21K | ---- | --14.11M | --15.31M | ---- | ---- | 115.54%3.4M | 110.21%3.32M | -85.54%1.58M |
Adjustment items | ---- | ---- | ---- | ---- | ---- | ---- | ---803K | ---- | ---- | ---- |
Operating profit before the change of operating capital | 13.73%-2.53M | -4.64%-5.99M | -221.30%-2.93M | 63.90%-5.73M | 92.42%-911K | -368.11%-15.87M | 3.26%-12.02M | 89.30%-3.39M | -282.89%-12.42M | 45.74%-31.68M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 1,412.38%3.06M | 277.08%6.73M | -85.84%202K | -267.44%-3.8M | 120.08%1.43M | 141.77%2.27M | -35.09%-7.11M | -307.88%-5.43M | -297.78%-5.26M | -91.03%2.61M |
Accounts receivable (increase)decrease | 58.90%12.15M | -152.61%-2.92M | 164.54%7.65M | 337.08%5.54M | -27.54%-11.85M | -103.71%-2.34M | -112.81%-9.29M | -81.35%62.99M | -75.52%72.52M | 187.37%337.73M |
Accounts payable increase (decrease) | 58.95%-3.59M | -149.23%-5.61M | -174.64%-8.74M | 213.67%11.4M | 246.23%11.71M | 17.05%-10.03M | 117.36%3.38M | 96.31%-12.09M | 94.01%-19.48M | -221.00%-327.43M |
Cash from business operations | 337.75%9.09M | -205.07%-7.79M | -1,098.17%-3.82M | 128.56%7.42M | 101.53%383K | -161.73%-25.97M | -170.78%-25.03M | 324.20%42.07M | 219.05%35.36M | 87.07%-18.76M |
Other taxs | 325.20%286K | 66.00%-256K | ---127K | -1,348.08%-753K | ---- | 93.13%-52K | ---1.08M | 82.84%-757K | ---- | -36,658.33%-4.41M |
Interest received - operating | -94.37%4K | -70.45%52K | 184.00%71K | 238.46%176K | 316.67%25K | 6.12%52K | -85.71%6K | -94.30%49K | -94.44%42K | -52.20%860K |
Net cash from operations | 341.79%9.38M | -216.92%-8M | -1,050.74%-3.88M | 126.34%6.84M | 101.56%408K | -162.78%-25.97M | -173.73%-26.1M | 285.35%41.36M | 221.95%35.4M | 84.44%-22.32M |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | ---- | ---- | ---- | -563.86%-19.84M | -563.86%-19.84M | --4.28M | --4.28M | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 314.20%113.42M |
Sale of fixed assets | ---- | 628.57%51K | --12K | -96.71%7K | ---- | --213K | --206K | ---- | ---- | -91.76%1.42M |
Purchase of fixed assets | 98.76%-31K | -486.67%-3.26M | -986.09%-2.5M | 56.33%-555K | 81.70%-230K | 25.54%-1.27M | 19.42%-1.26M | 1.44%-1.71M | -70.87%-1.56M | 79.48%-1.73M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---156K | ---- | ---- | ---- | 223.11%14.77M | --14.77M | ---12M |
Recovery of cash from investments | ---- | ---- | ---- | -80.14%9.69M | -80.27%9.62M | --48.78M | --48.78M | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---29.94M | ---- | ---- |
Other items in the investment business | ---- | ---- | ---- | ---68K | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 98.75%-31K | 70.67%-3.21M | 76.21%-2.49M | -121.01%-10.93M | -120.09%-10.45M | 408.17%52M | 293.61%52.01M | -116.69%-16.87M | -80.69%13.21M | -56.73%101.11M |
Net cash before financing | 246.87%9.35M | -174.06%-11.2M | 36.62%-6.37M | -115.70%-4.09M | -138.76%-10.04M | 6.31%26.03M | -46.71%25.91M | -68.92%24.49M | 23.44%48.61M | -12.71%78.79M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.19%48.53M | -85.62%47.87M | 59.33%327.81M |
Refund | ---- | ---- | ---- | ---- | ---- | ---77.03M | ---40M | ---- | ---- | -100.20%-426.08M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | 160.75%79.05M | ---- | --30.32M | --17.6M | ---- |
Interest paid - financing | 9.52%-19K | 87.97%-32K | 90.95%-21K | 88.11%-266K | 70.78%-232K | 61.90%-2.24M | 75.05%-794K | 55.00%-5.87M | 70.33%-3.18M | -42.91%-13.05M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---98M | ---88M | ---- |
Net cash from financing operations | -12.74%-416K | 26.69%-780K | 25.00%-369K | 34.36%-1.06M | 98.82%-492K | 93.82%-1.62M | -54.33%-41.53M | 76.72%-26.22M | 56.94%-26.91M | -24.75%-112.6M |
Effect of rate | -3.64%-57K | 92.16%-20K | 24.66%-55K | -195.51%-255K | -107.40%-73K | -81.12%267K | -74.14%987K | -26.28%1.41M | -12.79%3.82M | -34.47%1.92M |
Net Cash | 232.64%8.93M | -132.60%-11.98M | 36.08%-6.73M | -121.10%-5.15M | 32.55%-10.54M | 1,511.10%24.41M | -171.96%-15.62M | 94.88%-1.73M | 193.92%21.71M | -483,100.00%-33.81M |
Begining period cash | -24.19%37.61M | -9.83%49.61M | -9.83%49.61M | 81.36%55.01M | 81.36%55.01M | -1.03%30.33M | -1.03%30.33M | -50.99%30.65M | -50.99%30.65M | 4.92%62.54M |
Cash at the end | 8.56%46.48M | -24.19%37.61M | -3.57%42.82M | -9.83%49.61M | 182.83%44.4M | 81.36%55.01M | -72.05%15.7M | -1.03%30.33M | 28.22%56.17M | -50.99%30.65M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --56.17M | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --56.17M | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.